Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial

被引：0
|
作者：
Nobuya Inagaki
Wenying Yang
Hirotaka Watada
Linong Ji
Sven Schnaidt
Egon Pfarr
Tomoo Okamura
Odd Erik Johansen
Jyothis T. George
Maximilian von Eynatten
Julio Rosenstock
Vlado Perkovic
Christoph Wanner
Mark E. Cooper
John H. Alexander
Issei Komuro
Masaomi Nangaku
机构：
[1] Kyoto University,Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine
[2] China-Japan Friendship Hospital,Department of Endocrinology
[3] Juntendo University Graduate School of Medicine,Department of Metabolism and Endocrinology
[4] Peking University People’s Hospital,Department of Endocrinology and Metabolism
[5] Boehringer Ingelheim Pharma GmbH & Co KG,Dallas Diabetes Research Center at Medical City
[6] Boehringer Ingelheim Pharma GmbH & Co KG,George Institute for Global Health, Faculty of Medicine
[7] Nippon Boehringer Ingelheim Co.,Division of Nephrology, Department of Medicine
[8] Ltd,Department of Diabetes, Central Clinical School
[9] Boehringer Ingelheim Norway KS,Department of Cardiovascular Medicine
[10] Boehringer Ingelheim International GmbH,Division of Nephrology and Endocrinology
[11] University of Texas Southwestern Medical Center,undefined
[12] University of New South Wales,undefined
[13] Würzburg University Clinic,undefined
[14] Monash University,undefined
[15] Duke Clinical Research Institute,undefined
[16] Duke Health,undefined
[17] University of Tokyo Hospital,undefined
[18] The University of Tokyo Graduate School of Medicine,undefined
来源：
Diabetology International | 2020年 / 11卷
关键词：
Diabetes mellitus, type 2; Cardiovascular diseases; Renal insufficiency, chronic; Prescription drugs;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：129 / 141
页数：12
相关论文
共 50 条
  • [31] Type 2 Diabetes, Chronic Kidney Disease, and Mortality in Patients with Established Cardiovascular Disease
    Saely, Christoph H.
    Vonbank, Alexander
    Lins, Christina
    Zanolin, Daniela
    Leiherer, Andreas
    Schuler, Alxandra
    Ebner, Karl-Martin
    Rein, Philipp
    Muendlein, Axel
    Drexel, Heinz
    DIABETES, 2017, 66 : A2 - A2
  • [32] TYPE 2 DIABETES, CHRONIC KIDNEY DISEASE, AND MORTALITY IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Zanolin, D.
    Leiherer, A.
    Mader, A.
    Larcher, B.
    Muendlein, A.
    Drexel, H.
    ATHEROSCLEROSIS, 2018, 275 : E202 - E203
  • [33] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Zanolin, D.
    Leiherer, A.
    Schuler, A.
    Rein, P.
    Muendlein, A.
    Mader, A.
    Schwerzler, P.
    Drexel, H.
    DIABETOLOGIA, 2017, 60 : S515 - S515
  • [34] Type 2 diabetes, chronic kidney disease, and mortality in patients with established cardiovascular disease
    Saely, C. H.
    Vonbank, A.
    Lins, C.
    Zanolin, D.
    Leiherer, A.
    Schuler, A.
    Schwerzler, P.
    Mader, A.
    Rein, P.
    Muendlein, A.
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S63 - S63
  • [35] Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial
    Rosenstock, Julio
    Kahn, Steven E.
    Johansen, Odd Erik
    Zinman, Bernard
    Espeland, Mark A.
    Woerle, Hans J.
    Pfarr, Egon
    Keller, Annett
    Mattheus, Michaela
    Baanstra, David
    Meinicke, Thomas
    George, Jyothis T.
    von Eynatten, Maximilian
    McGuire, Darren K.
    Marx, Nikolaus
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (12): : 1155 - 1166
  • [36] Type 2 Diabetes, Chronic Kidney Disease, and Major Cardiovascular Events in Patients With Established Cardiovascular Disease
    Sprenger, Lukas
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    CIRCULATION, 2022, 146
  • [37] Type 2 diabetes, chronic kidney disease and major cardiovascular events In patients with established cardiovascular disease
    Sprenger, L.
    Maechler, M.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 2) : 170 - 171
  • [38] Type 2 Diabetes, Chronic Kidney Disease, and Major Cardiovascular Events in Patients with Established Cardiovascular Disease
    Sprenger, Lukas
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2022, 71
  • [39] TYPE 2 DIABETES, CHRONIC KIDNEY DISEASE AND MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE
    Sprenger, L.
    Maechler, M.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Plattner, T.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C.
    ATHEROSCLEROSIS, 2023, 379
  • [40] Type 2 diabetes, chronic kidney disease and major cardiovascular events in patients with established cardiovascular disease
    Sprenger, Lukas
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 261 - 261
12345